Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Yuliya Sidneva"'
Autor:
Ludmila Astafyeva, Inna Badmaeva, Irina Klochkova, Oleg Sharipov, Yuliya Sidneva, Olga Gadjieva, Boris Bashiryan, Pavel Kalinin, Andrei Lubnin, Aleksandr Konovalov
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48ea8440a255874d7d6c34429b9fd3e0
https://doi.org/10.1530/endoabs.90.ep871
https://doi.org/10.1530/endoabs.90.ep871
Autor:
Ludmila Astafyeva, Alexsey Shkarubo, R.A. Ibrahim Sameh, Inna Badmaeva, Yuliya Sidneva, Julia Strunina, Maxim Kutin, Dmitrii Fomicev, Oleg Sharipov, Dmitrii Andreev, Ilya Chernov, Pavel Kalinin
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65d0ce13529fb146b73cbd3ae2bc70eb
https://doi.org/10.1530/endoabs.81.ep669
https://doi.org/10.1530/endoabs.81.ep669
Autor:
Ludmila Astafyeva, Yuliya Sidneva, Inna Badmaeva, Pavel Kalinin, Svetlana Valiullina, Andrey Marshintsev
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a714d9e861c4cc9762d3f93692c91c28
https://doi.org/10.1530/endoabs.81.ep1196
https://doi.org/10.1530/endoabs.81.ep1196
Publikováno v:
Ожирение и метаболизм, Vol 17, Iss 1, Pp 33-40 (2020)
The relevance of cachexia syndrome is determined by its high prevalence in clinical practice. It accompanies the course of not only oncological diseases, but also the majority of chronic somatic pathologies, such as chronic heart failure, renal failu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f49e392dddca7a76d14401da2862eb24
https://doi.org/10.14341/omet10173
https://doi.org/10.14341/omet10173
Autor:
Larisa Dzeranova, Pavel Kalinin, Ludmila I. Astafyeva, Maxim Kutin, Yuliya Sidneva, Boris A. Kadashev
Publikováno v:
Ожирение и метаболизм, Vol 16, Iss 2, Pp 83-88 (2019)
The article presents a clinical case from the practice of a patient with craniopharyngioma. The man of reproductive age with diencephalic obesity (BMI 35 kg/m2), recurrent craniopharyngioma, a long history of endocrine disorders (panhypopituitarism,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4f78c4fe8462d1cc32c63820a3c8b09
https://www.omet-endojournals.ru/jour/article/view/10062
https://www.omet-endojournals.ru/jour/article/view/10062
Autor:
Yuliya Sidneva, Kalinin Pl, Shukur Abdulatipov, Irina Voronina, Ludmila I. Astafyeva, Maxim Kutin, Oleg Zaitsev, Dmitry Nikolaevich Andreev, Sergey Urakov, Oleg Sharipov, Iliay Chernov, D. V. Fomichev, Aleksey Shkarubo, Boris A. Kadashev
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04a9c191b85892e3165eb66898f940bc
https://doi.org/10.1530/endoabs.70.aep545
https://doi.org/10.1530/endoabs.70.aep545
Autor:
Ludmila I. Astafyeva, Yuliya Sidneva
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54a4fadf09c0b7d3d557b1000961c301
https://doi.org/10.1530/endoabs.70.ep408
https://doi.org/10.1530/endoabs.70.ep408
Autor:
Maxim Kutin, Yuliya Sidneva, Larisa Dzeranova, Dina A. Yatsenko, Ludmila I. Astafyeva, Pavel Kalinin, Ilya V. Chernov, D. B. Ismailov, Boris A. Kadashev
Publikováno v:
Эндокринная хирургия, Vol 11, Iss 4, Pp 201-208 (2018)
Cerebrospinal fluid (CSF) leak is a rare complication in of the prolactinomas treatment with dopamine agonists. In most cases CSF leak develops within the first three months of treatment starting. The article presents a rare clinical case – later d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8e1babc9e85345a06c190d7e4df16aa
https://doi.org/10.14341/serg9485
https://doi.org/10.14341/serg9485
Autor:
Pavel Kalinin, Boris A. Kadashev, L I Astaf'eva, S A Agadzhanian, Galina A. Melnichenko, Yuliya Sidneva
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-6 (2019)
Summary A 32-year-old woman presented with primary amenorrhoea, prolactin (PRL) level of 154 150 mIU/L and was diagnosed with a giant pituitary adenoma measuring maximum 6.2 cm. Cabergoline (CAB) treatment at a dose of 0.5 mg/week was prescribed to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff8cf45174bad157a361da5fca05d449
https://doi.org/10.1530/edm-19-0023
https://doi.org/10.1530/edm-19-0023
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c31cd3976425bfe4fb62e35c9d1a243
https://doi.org/10.1530/endoabs.63.ep97
https://doi.org/10.1530/endoabs.63.ep97